| |
| |
|
| Insider
Information: |
Pomerantz Roger |
| Relationship: |
Director |
| City: |
Chalfont |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
314,251 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$277,088 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
314,251 |
|
|
| Total
Value |
$277,088 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seres Therapeutics, Inc. |
MCRB |
President and CEO, Dir... |
2018-09-07 |
213,976 |
2015-06-26 |
0 |
Premium* |
|
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
800 |
2017-07-25 |
0 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
100 |
2018-07-20 |
0 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2024-02-25 |
99,375 |
2022-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
70 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,727 |
22,727 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
27,102 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
36,136 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
45,170 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
54,204 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
63,238 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,035 |
72,273 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
81,307 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
90,341 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2024-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
99,375 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-04-01 |
4 |
OE |
$0.48 |
$43,662 |
D/D |
90,963 |
113,690 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-04-04 |
4 |
OE |
$0.48 |
$21,516 |
D/D |
44,825 |
67,552 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-04-07 |
4 |
OE |
$0.48 |
$6,147 |
D/D |
9,212 |
31,939 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-02 |
4 |
OE |
$0.71 |
$31,018 |
D/D |
43,687 |
66,414 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-03 |
4 |
OE |
$0.71 |
$16,813 |
D/D |
23,680 |
46,407 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-04 |
4 |
OE |
$0.71 |
$20,802 |
D/D |
29,298 |
23,427 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-05 |
4 |
OE |
$0.71 |
$21,319 |
D/D |
30,027 |
31,627 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-06 |
4 |
OE |
$0.71 |
$6,040 |
D/D |
8,507 |
31,234 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-18 |
4 |
OE |
$0.71 |
$114,285 |
D/D |
160,965 |
183,692 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-05-24 |
4 |
OE |
$0.71 |
$6,959 |
D/D |
9,801 |
193,493 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-06-01 |
4 |
OE |
$0.71 |
$50,375 |
D/D |
70,951 |
254,643 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-06-02 |
4 |
OE |
$0.71 |
$52,575 |
D/D |
74,049 |
257,741 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-07-01 |
4 |
OE |
$0.71 |
$40,320 |
D/D |
56,789 |
240,481 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-07-05 |
4 |
OE |
$0.71 |
$37,471 |
D/D |
52,776 |
236,468 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2016-07-06 |
4 |
OE |
$0.71 |
$25,159 |
D/D |
35,435 |
219,127 |
0 |
- |
|
70 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
